Literature DB >> 33780142

A method for quantitative evaluations of scanning-proton dose distributions.

Bryce C Allred1, Jie Shan1, Daniel G Robertson1, Todd A DeWees2, Jiajian Shen1, Wei Liu1, Joshua B Stoker1.   

Abstract

PURPOSE: Patient-Specific Quality Assurance (PSQA) measurement analysis depends on generating metrics representative of calculation and measurement agreement. Considering the heightened capability of discrete spot scanning protons to modulate individual dose voxels, a dose plane comparison approach that maintained all of the capabilities of the well-established γ test, but that also provided a more intuitive error parameterization, was desired.
METHODS: Analysis was performed for 300 dose planes compared by searching all calculated points within a fixed radius around each measured pixel to determine the dose deviation. Dose plane agreement is reported as the dose difference minimum (DDM) within an empirically established search radius: ΔDmin(r). This per-pixel metric is aggregated into a histogram binned by dose deviation. Search-radius criteria were based on a weighted-beamlet 3σ spatial deviation from imaging isocenter. Equipment setup error was mitigated during analysis using tracked image registration, ensuring beamlet deviations to be the dominant source of spatial error. The percentage of comparison points with <3% dose difference determined pass rate.
RESULTS: The mean beamlet radial deviation was 0.38mm from x-ray isocenter, with a standard deviation of 0.19mm, such that 99.9% of relevant pencil beams were within 1 mm of nominal. The dose-plane comparison data showed no change in passing rate between a 3%/1mm ΔDmin(r) analysis (97.6 +/- 3.6%) and a 3%/2mm γ test (97.7 +/- 3.2%).
CONCLUSIONS: PSQA dose-comparison agreements corresponding to a search radius outside of machine performance limits are likely false positives. However, the elliptical shape of the γ test is too dose-restrictive with a spatial-error threshold set at 1 mm. This work introduces a cylindrical search shape, proposed herein as more relevant to plan quality, as part of the new DDM planar-dose comparison algorithm. DDM accepts all pixels within a given dose threshold inside the search radius, and carries forward plan-quality metrics in a straightforward manner for evaluation.
© 2021 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals LLC on behalf of American Association of Physicists in Medicine.

Entities:  

Keywords:  PSQA; gamma test; proton

Year:  2021        PMID: 33780142      PMCID: PMC8035555          DOI: 10.1002/acm2.13226

Source DB:  PubMed          Journal:  J Appl Clin Med Phys        ISSN: 1526-9914            Impact factor:   2.102


  17 in total

1.  On dose distribution comparison.

Authors:  Steve B Jiang; Greg C Sharp; Toni Neicu; Ross I Berbeco; Stella Flampouri; Thomas Bortfeld
Journal:  Phys Med Biol       Date:  2006-01-25       Impact factor: 3.609

2.  IMRT commissioning: multiple institution planning and dosimetry comparisons, a report from AAPM Task Group 119.

Authors:  Gary A Ezzell; Jay W Burmeister; Nesrin Dogan; Thomas J LoSasso; James G Mechalakos; Dimitris Mihailidis; Andrea Molineu; Jatinder R Palta; Chester R Ramsey; Bill J Salter; Jie Shi; Ping Xia; Ning J Yue; Ying Xiao
Journal:  Med Phys       Date:  2009-11       Impact factor: 4.071

3.  A technique for the quantitative evaluation of dose distributions.

Authors:  D A Low; W B Harms; S Mutic; J A Purdy
Journal:  Med Phys       Date:  1998-05       Impact factor: 4.071

4.  AAPM task group 224: Comprehensive proton therapy machine quality assurance.

Authors:  Bijan Arjomandy; Paige Taylor; Christopher Ainsley; Sairos Safai; Narayan Sahoo; Mark Pankuch; Jonathan B Farr; Sung Yong Park; Eric Klein; Jacob Flanz; Ellen D Yorke; David Followill; Yuki Kase
Journal:  Med Phys       Date:  2019-06-14       Impact factor: 4.071

5.  A novel and fast method for proton range verification using a step wedge and 2D scintillator.

Authors:  Jiajian Shen; Bryce C Allred; Daniel G Robertson; Wei Liu; Terence T Sio; Nicholas B Remmes; Sameer R Keole; Martin Bues
Journal:  Med Phys       Date:  2017-07-31       Impact factor: 4.071

6.  Technical Note: Relationships between gamma criteria and action levels: Results of a multicenter audit of gamma agreement index results.

Authors:  Scott B Crowe; Bess Sutherland; Rachael Wilks; Venkatakrishnan Seshadri; Steven Sylvander; Jamie V Trapp; Tanya Kairn
Journal:  Med Phys       Date:  2016-03       Impact factor: 4.071

Review 7.  Tolerance limits and methodologies for IMRT measurement-based verification QA: Recommendations of AAPM Task Group No. 218.

Authors:  Moyed Miften; Arthur Olch; Dimitris Mihailidis; Jean Moran; Todd Pawlicki; Andrea Molineu; Harold Li; Krishni Wijesooriya; Jie Shi; Ping Xia; Nikos Papanikolaou; Daniel A Low
Journal:  Med Phys       Date:  2018-03-23       Impact factor: 4.071

8.  Institutional patient-specific IMRT QA does not predict unacceptable plan delivery.

Authors:  Stephen F Kry; Andrea Molineu; James R Kerns; Austin M Faught; Jessie Y Huang; Kiley B Pulliam; Jackie Tonigan; Paola Alvarez; Francesco Stingo; David S Followill
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-10-21       Impact factor: 7.038

9.  Moving from gamma passing rates to patient DVH-based QA metrics in pretreatment dose QA.

Authors:  Heming Zhen; Benjamin E Nelms; Wolfgang A Tome
Journal:  Med Phys       Date:  2011-10       Impact factor: 4.071

10.  The sensitivity of gamma-index method to the positioning errors of high-definition MLC in patient-specific VMAT QA for SBRT.

Authors:  Jung-In Kim; So-Yeon Park; Hak Jae Kim; Jin Ho Kim; Sung-Joon Ye; Jong Min Park
Journal:  Radiat Oncol       Date:  2014-07-28       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.